Work

A Randomized, Double-Blind, Placebo-Controlled Trial of Omalizumab Combined with Oral Immunotherapy (OIT) in the Treatment of Cow's Milk Allergy (CMA): Safety of Dosing

Year: 2014

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2013.12.1067

Authors: Jennifer S. Kim, Robert A. Wood, Robert Lindblad, Sally A. Noone, Melissa N. Paterakis, Alice Henning, Kari C. Nadeau, Kyrsten Spann, Hugh A. Sampson

Institutions: Icahn School of Medicine at Mount Sinai, Johns Hopkins University, Johns Hopkins Hospital, Emmes (United States), Stanford University

Language: English

Topic: Food Allergy and Anaphylaxis Research

Subfield: Immunology and Allergy

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2118763755

FWCI: 0.643

Cites:

Cited by: 3

Related to: 10